怀孕和哺乳期相关骨质疏松症后的第二个孩子 (PLO) 用特里巴拉提德治疗:一个病例报告
Shinsuke Yamada1, Noriyuki Hayashi2, Norikazu Toi3
1Clinical Immunology, Osaka Metropolitan University of Medicine, Osaka, JPN.
Cureus
|August 19, 2024
概括
怀孕和哺乳期相关的骨质疏松症 (PLO) 是罕见但严重的. 一名为PLO治疗teriparatide的患者成功地生了另一个健康的孩子,没有复发,这表明潜在的治疗益处.
科学领域:
- 生殖医学是一种生殖医学.
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 怀孕和哺乳期相关的骨质疏松症 (PLO) 是一种罕见但严重的疾病.
- 它通常在怀孕后期或产后早期表现出来.
- 害怕复发往往会阻止受影响个体在未来怀孕.
研究的目的:
- 在积极治疗骨质疏松症后报告一个成功怀孕的案例.
- 为了评估teriparatide在患有PLO病史的患者中的安全性和有效性.
- 为了解决有关后期怀孕中复发风险的担忧.
主要方法:
- 一个29岁的女性患者被诊断出患有PLO的病例报告.
- 使用 teriparatide 的侵袭性骨质疏松症治疗.
- 通过随后的怀孕和分娩监测患者的结果.
主要成果:
- 患者在33岁时怀孕并分娩了一个健康的孩子.
- 在随后的怀孕期间没有观察到PLO的复发.
- 特里巴拉提德治疗与成功的怀孕结果有关.
结论:
- 对那些希望在未来怀孕的PLO妇女来说,特里巴拉提德可能是一个可行的治疗选择.
- 需要进一步的研究和案例研究来证实有效性和安全性.
- 这个案例为管理PLO和生育年龄妇女的复发焦虑提供了希望.
相关概念视频
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K


